Mendus0,415 SEK −3,27 %
Mendus is active in medical technology. The company produces therapeutic vaccines used in the field of oncology. The company mainly drives development in immunotherapy with a focus on the treatment of serious tumors. Examples of diseases that the products are used against include kidney and liver cancer. The largest activity is found within the Nordic market. The company previously went by the name Immunicum and today has its headquarters in Stockholm.